[1]
SANKARAIAH, J. et al. 2021. FORMULATION AND EVALUATION OF FIXED-DOSE COMBINATION OF BILAYER TABLETS OF ATAZANAVIR SULFATE AND RITONAVIR 300 MG/100 MG. International Journal of Applied Pharmaceutics. 13, 5 (Sep. 2021), 60–72. DOI:https://doi.org/10.22159/ijap.2021v13i5.41860.